ERK1 Protein, Human (Active, GST)

Customer Review

Based on 1 Customer Validation

ERK1 protein is an important serine/threonine kinase in the MAP kinase pathway and cooperates with MAPK1/ERK2 to activate the MAPK/ERK cascade. Stimulated by KIT and KITLG/SCF, this pathway plays a key role in cell growth, adhesion, survival, and differentiation. ERK1 Protein, Human (GST) is the recombinant human-derived ERK1 protein, expressed by E. coli , with N-GST labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: E. coli
  • Storage:
    Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

ERK1 protein is an important serine/threonine kinase in the MAP kinase pathway and cooperates with MAPK1/ERK2 to activate the MAPK/ERK cascade. Stimulated by KIT and KITLG/SCF, this pathway plays a key role in cell growth, adhesion, survival, and differentiation. ERK1 Protein, Human (GST) is the recombinant human-derived ERK1 protein, expressed by E. coli , with N-GST labeled tag.

Background

ERK1, a serine/threonine kinase, stands as a vital component in the MAP kinase signal transduction pathway, working in concert with MAPK1/ERK2 to orchestrate the MAPK/ERK cascade. This pathway, activated by stimuli such as KIT and KITLG/SCF, plays a pivotal role in diverse biological functions, including cell growth, adhesion, survival, and differentiation. ERK1, along with MAPK1/ERK2, influences transcription, translation, and cytoskeletal rearrangements, while also contributing to the initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells through the phosphorylation of numerous transcription factors. With approximately 160 substrates identified for ERKs, their targets span various cellular compartments, participating in processes such as transcription regulation, translation, mitosis, and apoptosis. Additionally, the MAPK/ERK cascade is implicated in endosomal dynamics, lysosome processing, endosome cycling through the perinuclear recycling compartment (PNRC), and the fragmentation of the Golgi apparatus during mitosis. Noteworthy substrates include transcription factors, cytoskeletal elements, regulators of apoptosis, regulators of translation, as well as diverse signaling-related molecules, protein kinases, and phosphatases, thereby extending the cascade's specificity and amplifying its impact on cellular responses.

Verified Bioactivity

The enzyme was incubated with fluorecence-labeled substrate and Mg(or Mn)/ATP. The phosphorylated and unphosphorylated substrates were separated and detected by MSA device. The conversion rate of ERK1 is 30% when it reacts with 20 μM ATP and 2 μM Peptide 8 for 30 minutes, and the corresponding enzyme concentration is 25 nM.

Technical Parameters

  • Species Human
  • Source E. coli
  • Tag N-GST
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • GST
    • ERK1 (A2-P379)
      Accession # P27361
    • C-term
  • Protein Length

    Full Length of Mature Protein

  • Synonyms

    MAPK3; P44-MAPK; Prev. PRKM3; Extracellular Signal-Related Kinase 1; ERK1; Mitogen-Activated Protein Kinase; P44mapk; MAP Kinase Isoform P44; P44erk1; MAP Kinase 3; ERK-1; HS44KDAP; Extracellular Signal-Regulated Kinase 1; HUMKER1A; Microtubule-Associated

  • AA Sequence

    AAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP

  • Predicted Molecular Mass

    69.3 kDa

  • Purity

    ≥ 85%, as determined by reducing SDS-PAGE.

Product Properties

Appearance

Solution.

Formulation

Supplied as a 0.22 μm filtered solution of 50 mM Tris-HCl, pH 7.5, 200 mM NaCl, 20% glycerol,1 mM DTT.
Note: For SPR assay, please replace the buffer. Primary amine components (e.g., Tris, imidazole) can affect protein-coupled chips.

Endotoxin Level

<1 EU/μg, determined by LAL method.

Reconstitution

Please use rapid thawing with running water to thaw the protein.

Storage & Stability

Stored at -80°C for 1 year from date of receipt. It is stable at -20°C for 3 months after opening. It is recommended to freeze aliquots at -80°C for extended storage. Avoid repeated freeze-thaw cycles.

Shipping

Shipping with dry ice.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00